18 February 2019 | News
ENU Nutrition products were developed in collaboration with registered dietitians from leading academic and community cancer centers in the United States.
Cambrooke Therapeutics, a member of The Ajinomoto Group, and Trovita Health Science, a specialty medical nutrition company, announce a joint marketing and development partnership for ENU®Nutrition meal replacement shakes.
ENU Nutrition products were developed in collaboration with registered dietitians from leading academic and community cancer centers in the United States to help those seeking a highly nutritious, more natural, non-GMO nutrition supplement drink. Trovita launched ENU in 2014, and more than two million servings have been consumed by a wide range of consumers, including those with oncology nutrition needs, cystic fibrosis and even elite athletes—all who share a desire for high quality, calorically dense nutrition.
Cambrooke’s acquisition of the ENU brand and strategic alliance with Trovita will allow more patients to benefit from ENU. Cambrooke will manufacture ENU in its Ayer manufacturing facility, and Trovita Health Science will continue to market and distribute ENU. The strategic partnership includes new product development guided by the global nutrition R&D powerhouse in Cambrooke’s parent company, Ajinomoto.